Literature DB >> 29514798

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Leila R Zelnick1, Ian H de Boer2, Bryan R Kestenbaum2, Michel Chonchol3, Jessica Kendrick3,4.   

Abstract

Entities:  

Keywords:  25-hydroxyvitamin D; Calcifediol; Calcitriol; Cholecalciferol; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydroxycholecalciferols; Fibroblast Growth Factors; Minerals; Renal Insufficiency, Chronic; Vitamin D; Vitamin D3 24-Hydroxylase; chronic kidney disease; clinical trial; mineral metabolism; obesity; parathyroid hormone

Mesh：

Substances：

Year:  2018        PMID： 29514798      PMCID： PMC5989680          DOI： 10.2215/CJN.00480118

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  5 in total

1.  Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial.

Authors:  Csaba P Kovesdy; Jun L Lu; Sandra M Malakauskas; Dennis L Andress; Kamyar Kalantar-Zadeh; Shahram Ahmadzadeh
Journal:  Am J Kidney Dis       Date:  2011-08-31       Impact factor: 8.860

2.  Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.

Authors:  Jessica Kendrick; Emily Andrews; Zhiying You; Kerrie Moreau; Kristen L Nowak; Heather Farmer-Bailey; Douglas R Seals; Michel Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-07       Impact factor: 8.237

3.  Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.

Authors:  Jason R Stubbs; Shiqin Zhang; Peter A Friedman; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-02       Impact factor: 8.237

Review 4.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

5.  Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.

Authors:  Zona Batacchi; Cassianne Robinson-Cohen; Andrew N Hoofnagle; Tamara Isakova; Bryan Kestenbaum; Kevin J Martin; Myles S Wolf; Ian H de Boer
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-02       Impact factor: 8.237
  5 in total
  3 in total

1.  The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease.

Authors:  Mandy E Turner; Tyler S Rowsell; Christine A White; Martin Kaufmann; Patrick A Norman; Kathryn Neville; Martin Petkovich; Glenville Jones; Michael A Adams; Rachel M Holden
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

2.  Vitamin D Metabolic Ratio and Risks of Death and CKD Progression.

Authors:  Nisha Bansal; Ronit Katz; Lawrence Appel; Michelle Denburg; Harold Feldman; Alan S Go; Jiang He; Andrew Hoofnagle; Tamara Isakova; Bryan Kestenbaum; John Kusek; James Lash; Mary Leonard; Mahboob Rahman; Cassianne Robinson-Cohen; Myles Wolf; Dawei Xie; Leila Zelnick; Ian H de Boer
Journal:  Kidney Int Rep       Date:  2019-08-30

Review 3.  Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together?

Authors:  Marta Ziemińska; Beata Sieklucka; Krystyna Pawlak
Journal:  Nutrients       Date:  2021-03-01       Impact factor: 5.717
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.